The test is compatible with lateral flow technology and could be used to provide tuberculosis testing in low-resource settings.

Copenhagen-based SNIPR Biome, a biotech company focused on developing precision medicines through CRISPR technology for ...

SNIPR Biome ApS (“SNIPR”), the company pioneering the development of microbial CRISPR-medicine, today announced the close of a EUR 35 million Series B raise with funding from new investors the Cystic ...

Editas' share price has struggled due to clinical setbacks, but recent focus on in-vivo gene editing offers renewed hope and ...

The amorphous proteins, which are prevalent throughout the human body, adhere to nerve cells like plaque, inhibiting their ...

"We discovered that bacteria all around us are using amyloids as a molecular suit of armor," said senior author Aaron ...

Method swaps out a single amino acid which halts spread of diseaseA collaborative research team has developed a novel genetic ...

The images showed clearly that the resistant strains completely coated themselves in a type of amyloid protein called curli, ...